"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians ‪"‬ PeerVoice Internal Medicine Audio

Visit https://www.peervoice.com/XUP860 to view the entire programme with slides. After completing “"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians
"”, participants will be able to: Describe the role of nonsteroidal mineralocorticoid receptor antagonists (MRAs) as part of an overall treatment strategy to improve renal and cardiovascular outcomes for patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM); Outline the emerging standards of care for management of patients with CKD and T2DM, based on the “four-pillar” approach; and Explain the rationale for the recent updates in management guidelines for patients with CKD and T2DM.